Patent details

Basic Information

Publication number:

EP3344231

PCT Application Number:

US2016050110

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168430650

PCT Publication Number:

WO2017040928

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

STABILIZED GLUCAGON SOLUTIONS

French Title of Invention:

SOLUTIONS STABILISÉES DE GLUCAGON

German Title of Invention:

STABILISIERTE GLUCAGONLÖSUNGEN

SPC Number:

Dates

Filing date:

02/09/2016

Grant date:

13/04/2022

EP Publication Date:

11/07/2018

PCT Publication Date:

09/03/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/04/2022

EP B1 Publication Date:

13/04/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/09/2022

Expiration date:

02/09/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/04/2022

 

 

Name:

Latitude Pharmaceuticals, Inc.

Address:

6364 Ferris Square, San Diego, CA 92121, United States (US)

Inventor

1

Name:

CHEN, Hailiang

Address:

United States (US)

2

Name:

CHEN, Andrew Xian

Address:

United States (US)

3

Name:

ORIDA, Norman Keith

Address:

United States (US)

Priority

Priority Number:

201562214831 P

Priority Date:

04/09/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/08; A61K 38/26; A61P 3/08; A61K 9/00; A61K 47/02; A61K 47/20; A61K 47/26; A61K 47/10; A61K 47/18; A61K 47/12;

Publication

European Patent Bulletin

Issue number:

202215

Publication date:

13/04/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages